Connect with us

Health

UK approves GlaxoSmithKline drug to treat COVID-19

British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it “retains activity” against the new Omicron variant.

For more coronavirus news, visit our dedicated page.

The monoclonal antibody “was found to be safe and effective at reducing the risk of hospitalization and death in people with mild to moderate COVID-19 infection who are at an increased risk of developing severe disease,” said the Medicines and Healthcare products Regulatory Agency (MHRA).

Read more:

GSK says tests show Vir antibody drug works against Omicron

Moderna exec says company could have Omicron booster ready in March

Fauci: First US case of COVID-19 omicron variant identified

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

WHO to send one million polio vaccines to Gaza to protect children

The UN health agency said on Friday that it is sending more than a million polio vaccines to Gaza after the discovery of the highly infectious disease in sewage samples.

Continue Reading

Health

‘Endless nightmare’ of death and destruction in Gaza, UN officials tell Security Council

Senior UN officials on Friday reiterated the catastrophic humanitarian situation in Gaza, and escalating threat to aid workers, urging immediate action prevent further deterioration.

Continue Reading

Health

Europe tops the charts for alcohol consumption. WHO calls for urgent action to curb the trend

It seems that Europeans don’t want to give up booze. A UN World Health Organization (WHO) report has found that nothing has changed in the continent’s drinking habits. Despite the health risks, Europeans consume an average of 9.2 litres of pure alcohol a year – making them the world’s biggest drinkers.

Continue Reading

Trending